SLXP — SALIX PHARMACEUTICALS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
SLXP (SALIX PHARMACEUTICALS INC) is tracked on HoldingsHub across five years of quarterly 13F filings. 9 funds have reported positions historically, with the sum of their latest reported stakes valued at $6.71B. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
Major shareholders of SALIX PHARMACEUTICALS INC (SLXP) include MFS Investment Management, Renaissance Technologies, Northern Trust Corp, ranked by reported 13F value among the 9 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q1 2015 | 7 | 1.77M | $305.62M | -5.4% |
| Q4 2014 | 8 | 2.36M | $6.60B | +66.2% |
| Q3 2014 | 6 | 1.12M | $175.25M | -37.8% |
| Q2 2014 | 5 | 1.51M | $186.74M | +13.1% |
| Q1 2014 | 4 | 872.14K | $20.81B | -11.4% |
| Q4 2013 | 3 | 758.21K | $68.19M | +2.0% |
| Q3 2013 | 3 | 743.43K | $49.72M | +7.4% |
| Q2 2013 | 3 | 691.96K | $45.77M | +89.3% |
Over the 8 quarters shown, institutional share counts increased 156% in aggregate (Q2 2013 → Q1 2015); the largest single-quarter swing was Q2 2013 (+89.3%).
Top Institutional Holders (Q1 2015) — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 840.94K | $145.32M | 0.31% | Add | |
| 512.87K | $88.63M | 0.03% | Reduce | |
| 201.90K | $34.89M | 0.45% | Reduce | |
| 191.78K | $33.14M | 0.50% | New | |
| 14.95K | $2.58M | 0.00% | Add | |
| 5.00K | $864.00K | 0.01% | Reduce | |
| 1.10K | $191.00K | 0.00% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q4 2014 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 55.07K | $6.33B | 0.00% | Reduce | |
| 640.80K | $73.65M | 1.10% | Add | |
| 623.77K | $71.70M | 0.02% | Add | |
| 502.50K | $57.76M | 0.44% | Add | |
| 491.53K | $56.50M | 0.74% | New | |
| 41.42K | $4.76M | 0.01% | Reduce | |
| 6.98K | $802.00K | 0.00% | New | |
| 927 | $107.00K | 0.00% | Reduce |
Q3 2014 — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 538.12K | $84.08M | 0.03% | Add | |
| 205.08K | $32.04M | 0.02% | Reduce | |
| 180.00K | $28.12M | 0.41% | New | |
| 150.00K | $23.44M | 0.20% | Reduce | |
| 44.52K | $6.96M | 0.02% | Reduce | |
| 3.91K | $610.00K | 0.00% | Add |
Q2 2014 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 527.80K | $65.10M | 0.52% | New | |
| 509.14K | $62.80M | 0.02% | Reduce | |
| 257.82K | $31.80M | 0.07% | Add | |
| 216.91K | $26.76M | 0.01% | Add | |
| 2.23K | $273.00K | 0.00% | Add |
Q1 2014 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 200.16K | $20.74B | 0.01% | New | |
| 579.72K | $60.06M | 0.02% | Add | |
| 90.13K | $9.34M | 0.02% | Reduce | |
| 2.13K | $220.00K | 0.00% | Reduce |
Q4 2013 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 486.37K | $43.74M | 0.01% | Add | |
| 268.52K | $24.15M | 0.06% | Add | |
| 3.33K | $299.00K | 0.00% | Reduce |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 9 funds)
| Fund | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies | 840.94K | 41.42K | 44.52K | 257.82K | 90.13K | 268.52K | 262.10K | 338.32K | 53.72K |
| Northern Trust Corp | 512.87K | 623.77K | 538.12K | 509.14K | 579.72K | 486.37K | 477.18K | 350.18K | 310.94K |
| Soros Fund Management | 201.90K | 491.53K | — | — | — | — | — | — | — |
| Steadfast Capital Management | 191.78K | — | — | — | — | — | — | — | — |
| Legal & General Investment Management America | 14.95K | 6.98K | — | — | — | — | — | — | — |
| Point72 Asset Management | 5.00K | 502.50K | 150.00K | 527.80K | — | — | — | — | — |
| PNC Financial Services | 1.10K | 927 | 3.91K | 2.23K | 2.13K | 3.33K | 4.15K | 3.46K | 822 |
| MFS Investment Management | — | 55.07K | 205.08K | 216.91K | 200.16K | — | — | — | — |
| Corvex Management | — | 640.80K | 180.00K | — | — | — | — | — | — |
FAQ
Which funds hold SLXP?
9 funds have reported positions in SLXP across five years of 13F filings; the sum of their latest reported stakes is $6.71B.
Who are the top institutional holders of SLXP?
The largest 13F holders are MFS Investment Management, Renaissance Technologies, Northern Trust Corp, Corvex Management, Soros Fund Management; the top 25 are ranked at the top of this page.
Who are the major shareholders of SALIX PHARMACEUTICALS INC?
The major shareholders of SALIX PHARMACEUTICALS INC (SLXP) by reported 13F value are MFS Investment Management, Renaissance Technologies, Northern Trust Corp, Corvex Management, Soros Fund Management, among 9 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.